Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 27 articles:
HTML format
Text format



Single Articles


    March 2017

  1. Correction for Jeon et al., A set of NF-kappaB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer.
    Proc Natl Acad Sci U S A. 2017 Mar 13. pii: 201701795.
    PubMed     Text format    


    February 2017

  2. Correction for Shrivastava et al., Global long-range transport and lung cancer risk from polycyclic aromatic hydrocarbons shielded by coatings of organic aerosol.
    Proc Natl Acad Sci U S A. 2017 Feb 27. pii: 201702221.
    PubMed     Text format    


  3. TANG Y, Wang Z, Li Z, Kim J, et al
    High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.
    Proc Natl Acad Sci U S A. 2017 Feb 21. pii: 201612229.
    PubMed     Text format     Abstract available


    January 2017
  4. SHRIVASTAVA M, Lou S, Zelenyuk A, Easter RC, et al
    Global long-range transport and lung cancer risk from polycyclic aromatic hydrocarbons shielded by coatings of organic aerosol.
    Proc Natl Acad Sci U S A. 2017 Jan 23. pii: 201618475.
    PubMed     Text format     Abstract available


    November 2016
  5. OKIMOTO RA, Lin L, Olivas V, Chan E, et al
    Preclinical efficacy of a RAF inhibitor that evades paradoxical MAPK pathway activation in protein kinase BRAF-mutant lung cancer.
    Proc Natl Acad Sci U S A. 2016 Nov 9. pii: 201610456.
    PubMed     Text format     Abstract available


    September 2016
  6. YAN Y, Liu L, Xiong H, Miller JB, et al
    Functional polyesters enable selective siRNA delivery to lung cancer over matched normal cells.
    Proc Natl Acad Sci U S A. 2016 Sep 12. pii: 201606886.
    PubMed     Text format     Abstract available


    June 2016
  7. DAI YB, Miao YF, Wu WF, Li Y, et al
    Ablation of Liver X receptors alpha and beta leads to spontaneous peripheral squamous cell lung cancer in mice.
    Proc Natl Acad Sci U S A. 2016 Jun 22. pii: 201607590.
    PubMed     Text format     Abstract available


  8. KUDINOV AE, Deneka A, Nikonova AS, Beck TN, et al
    Musashi-2 (MSI2) supports TGF-beta signaling and inhibits claudins to promote non-small cell lung cancer (NSCLC) metastasis.
    Proc Natl Acad Sci U S A. 2016 Jun 6. pii: 201513616.
    PubMed     Text format     Abstract available


    February 2016
  9. TRIPATHI SC, Peters HL, Taguchi A, Katayama H, et al
    Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.
    Proc Natl Acad Sci U S A. 2016 Feb 29. pii: 201521812.
    PubMed     Text format     Abstract available


  10. SUBBIAH V, Hong DS, Meric-Bernstam F
    Clinical activity of ceritinib in ROS1-rearranged non-small cell lung cancer: Bench to bedside report.
    Proc Natl Acad Sci U S A. 2016 Feb 25. pii: 201522052.
    PubMed     Text format    


    January 2016
  11. OZTURK S, Papageorgis P, Wong CK, Lambert AW, et al
    SDPR functions as a metastasis suppressor in breast cancer by promoting apoptosis.
    Proc Natl Acad Sci U S A. 2016 Jan 6. pii: 201514663.
    PubMed     Text format     Abstract available


    November 2015
  12. YEDDULA N, Xia Y, Ke E, Beumer J, et al
    Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma.
    Proc Natl Acad Sci U S A. 2015;112:E6476-85.
    PubMed     Text format     Abstract available


    September 2015
  13. DAVARE MA, Vellore NA, Wagner JP, Eide CA, et al
    Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors.
    Proc Natl Acad Sci U S A. 2015;112:E5381-90.
    PubMed     Text format     Abstract available


    August 2015

  14. Retraction for Maitra et al., Mutant surfactant A2 proteins associated with familial pulmonary fibrosis and lung cancer induce TGF-beta1 secretion.
    Proc Natl Acad Sci U S A. 2015 Aug 24. pii: 201515456.
    PubMed     Text format    


  15. WANG Z, Shen Z, Li Z, Duan J, et al
    Activation of the BMP-BMPR pathway conferred resistance to EGFR-TKIs in lung squamous cell carcinoma patients with EGFR mutations.
    Proc Natl Acad Sci U S A. 2015;112:9990-5.
    PubMed     Text format     Abstract available


    July 2015
  16. CUI R, Meng W, Sun HL, Kim T, et al
    MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer.
    Proc Natl Acad Sci U S A. 2015 Jul 17. pii: 201502068.
    PubMed     Text format     Abstract available


  17. JOSHI P, Jeon YJ, Lagana A, Middleton J, et al
    MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC.
    Proc Natl Acad Sci U S A. 2015;112:8650-5.
    PubMed     Text format     Abstract available


  18. DUDA DG, Heist RS, Sahani DV, Stylianopoulos T, et al
    Reply to Ciccolini et al.: Using mathematical modeling to predict response to antiangiogenic therapy in cancer patients.
    Proc Natl Acad Sci U S A. 2015;112:E3454.
    PubMed     Text format    


  19. CICCOLINI J, Benzekry S, Lacarelle B, Barbolosi D, et al
    Improving efficacy of the combination between antiangiogenic and chemotherapy: Time for mathematical modeling support.
    Proc Natl Acad Sci U S A. 2015;112:E3453.
    PubMed     Text format    


  20. PHUCHAREON J, McCormick F, Eisele DW, Tetsu O, et al
    EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function.
    Proc Natl Acad Sci U S A. 2015 Jul 6. pii: 201510733.
    PubMed     Text format     Abstract available


    June 2015
  21. JEON YJ, Middleton J, Kim T, Lagana A, et al
    A set of NF-kappaB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer.
    Proc Natl Acad Sci U S A. 2015 Jun 15. pii: 201504630.
    PubMed     Text format     Abstract available


  22. ZHU X, Xu Y, Solis LM, Tao W, et al
    Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.
    Proc Natl Acad Sci U S A. 2015 Jun 8. pii: 201505629.
    PubMed     Text format     Abstract available


    March 2015
  23. NOJIRI T, Hosoda H, Tokudome T, Miura K, et al
    Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells.
    Proc Natl Acad Sci U S A. 2015;112:4086-91.
    PubMed     Text format     Abstract available


  24. SUN XX, He X, Yin L, Komada M, et al
    The nucleolar ubiquitin-specific protease USP36 deubiquitinates and stabilizes c-Myc.
    Proc Natl Acad Sci U S A. 2015;112:3734-9.
    PubMed     Text format     Abstract available


  25. QIAN J, Hassanein M, Hoeksema MD, Harris BK, et al
    The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers.
    Proc Natl Acad Sci U S A. 2015;112:3469-74.
    PubMed     Text format     Abstract available


    October 2014
  26. AUGUSTYN A, Borromeo M, Wang T, Fujimoto J, et al
    ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.
    Proc Natl Acad Sci U S A. 2014;111:14788-93.
    PubMed     Text format     Abstract available


    September 2014
  27. LAUBLI H, Pearce OM, Schwarz F, Siddiqui SS, et al
    Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
    Proc Natl Acad Sci U S A. 2014;111:14211-6.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: